Permissible and immunogenic HLA-A mismatches: Cytotoxic T cell precursor frequencies reflect graft survival data

Permissible and immunogenic HLA-A mismatches: Cytotoxic T cell precursor frequencies reflect graft survival data

Show other versions (1)

By analysis of the immunogenicity of single HLA mismatches in the context of the patients own HLA phenotype, Maruya et al. were able to define permissible and immunogenic HLA mismatches. Kidney graft survival in case of permissible mismatches was similar to that of completely HLA matched combination...

Full description

Bibliographic Details
Main Authors:	Roelen, D, Stobbe, I, Young, N, Van Bree, F, Doxiadis, I, Oudshoorn, M, Morris, P, Wood, K, Claas, F
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
by: Roelen, D, et al.
Published: (2001)

Association between CTL precursor frequency to HLA-C mismatches and HLA-C antigen cell surface expression
by: Moshe eIsraeli, et al.
Published: (2014-10-01)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
by: Vadim Jucaud
Published: (2017-01-01)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
by: Michiel G. H. Betjes, et al.
Published: (2020-01-01)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
by: Tomomi Hirama, et al.
Published: (2021-07-01)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
by: Mcadam, S, et al.
Published: (1995)

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations
by: Kirsten Geneugelijk, et al.
Published: (2019-04-01)

Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
by: Jon Jin Kim, et al.
Published: (2023-03-01)

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches
by: Heike Kunze-Schumacher, et al.
Published: (2014-01-01)

Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation
by: Claudia Lehmann, et al.
Published: (2023-01-01)

Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
by: McAdam, S, et al.
Published: (1995)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
by: Andrea Bacigalupo, et al.
Published: (2016-01-01)

Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants.
by: Rosenberg, WM, et al.
Published: (1992)

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
by: Mead, A, et al.
Published: (2010)

Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
by: Pooja Budhiraja, et al.
Published: (2025-01-01)

Corrigendum: Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
by: Jon Jin Kim, et al.
Published: (2023-03-01)

Predicting HLA class I non-permissive amino acid residues substitutions.
by: T Andrew Binkowski, et al.
Published: (2012-01-01)

Identification of HLA-DRB1 association to adalimumab immunogenicity.
by: Mohan Liu, et al.
Published: (2018-01-01)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
by: Sang Jin Kim, et al.
Published: (2022-11-01)

Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development
by: Vadim Jucaud
Published: (2024-07-01)

Explanation and Distinction of the Legal Nature of Permission as a Basis for Permissibility and Permission as a Basis for Agency (Permission as the Source of Permissibility and Permission as the Source of Agency)
by: Alireza Abbasi, et al.
Published: (2024-08-01)

HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes
by: Suzanne Bezstarosti, et al.
Published: (2022-01-01)

Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study
by: William Lemieux, et al.
Published: (2022-11-01)

Predicting HLA CD4 Immunogenicity in Human Populations
by: Sandeep Kumar Dhanda, et al.
Published: (2018-06-01)

Immunogenicity of Anti-HLA Antibodies in Pancreas and Islet Transplantation
by: Benjamin Chaigne, et al.
Published: (2016-11-01)

Allorecognition of HLA-C mismatches by CD8+ T cells in hematopoietic stem cell transplantation is a complex interplay between mismatched peptide binding region residues, HLA-C expression and HLA-DPB1 disparities
by: Florence Bettens, et al.
Published: (2016-12-01)

Studying Permission in Marriage: subrogated or permissible?
by: Muhammadmahdi Hamidi
Published: (2019-06-01)

Indirectly recognized HLA-C mismatches and their potential role in transplant outcome
by: Kirsten Anne Thus, et al.
Published: (2014-05-01)

HLA restriction of human cytotoxic T cells.
by: Mcmichael, A
Published: (1980)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
by: Sang Jin Kim, et al.
Published: (2022-12-01)

Influenza virus-specific cytotoxic T lymphocytes recognize HLA molecules. Blocking by monoclonal anti-HLA antibodies
by: Mcmichael, A, et al.
Published: (1980)

Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
by: Mcmichael, A, et al.
Published: (1980)

Mismatches in free relatives – grafting nanosyntactic trees
by: Fenna Bergsma
Published: (2019-11-01)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
by: Uroosa Ibrahim, et al.
Published: (2023-10-01)

Contract-Making Permission and Trust-Making Permission An Enquiry about the Various Functions of Permission
by: Mohammad Mehdi al-Sharif, et al.
Published: (2018-08-01)

HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
by: Kloverpris, H, et al.
Published: (2012)

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
by: Yvette L. Kasamon, et al.
Published: (2017-01-01)

Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
by: Rene J Duquesnoy
Published: (2011-11-01)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation
by: Emma T. M. Peereboom, et al.
Published: (2021-11-01)

Positive Mixed lymphocyte Culture Test Result Due to HLA-DP Mismatch
by: Tülay Kılıçaslan Ayna, et al.
Published: (2011-06-01)